Pfizer

A researcher at the University of Pittsburgh works on a COVID-19 vaccine candidate, a fingertip-size
Moderna, Pfizer start pivotal COVID-19 vaccine trials, eye year-end launch

The study is expected to include about 120 sites globally and could include up to 30,000 participants. It will include regions heavily impacted by COVID-19.

By REUTERS
28/07/2020
Moderna, Merck will not limit price of COVID-19 vaccines to company cost

Executives from Johnson & Johnson and AstraZeneca testified that they will price their respective potential vaccines at no profit while the pandemic rages on.

By REUTERS
22/07/2020
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use